A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations

by Erden Atilla, Pınar Ataca Atilla, Taner Demirer
Published 2017-02-01

New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology

by Mehmet Gunduz, Pinar Ataca Atilla, Erden Atilla
Published 2021-09-01

Successful Bosutinib Experience in an Elderly Acute Lymphoblastic Leukemia Patient with Suspected Central Nervous System Involvement Transformed from Chronic Myeloid Leukemia

by Erden Atilla, Pinar Ataca, Elif Ozyurek, Ilhan Erden, Gunhan Gurman
Published 2015-01-01

Successful Desensitization of a Patient with Rituximab Hypersensitivity

by Pinar Ataca, Erden Atilla, Resat Kendir, Sevim Bavbek, Muhit Ozcan
Published 2015-01-01

Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible?

by Erden Atilla, Ugur Sahin, Pinar Ataca Atilla, Mustafa Merter, Elif Ozyurek, Koray Ceyhan, Sinem Civriz Bozdag
Published 2019-12-01

Aspergillus Thyroiditis after Allogeneic Hematopoietic Stem Cell Transplantation

by Pinar Ataca, Erden Atilla, Pelin Saracoglu, Gulden Yilmaz, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Koray Ceyhan, Pervin Topcuoglu
Published 2015-01-01

Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experi...

by Pinar Ataca Atilla, Erden Atilla, Sinem Civriz Bozdag, Meltem Kurt Yuksel, Selami Kocak Toprak, Pervin Topcuoglu, Taner Demirer, Osman Ilhan, Onder Arslan, Gunhan Gurman, Muhit Ozcan
Published 2018-03-01

Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia

by Pinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, Madhuwanti Srinivasan, Feiyan Mo, Brian Wesley Simons, Alexandra McLean Stevens, Michele S Redell, Helen E Heslop, Erden Atilla
Published 2020-07-01